Clinical Trials Browser

Phase 1/2 × birinapant × Tumor-Agnostic × Clear all

NCT01188499 2016-05-30

Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

176 enrolled 13 charts

Neoplasms